|Year : 2016 | Volume
| Issue : 2 | Page : 125-127
Clinicopathological study of rare invasive epithelial tumors of breast: An institutional study
Karthik Kasireddy, K Manjula, C. S. B. R. Prasad
Department of Pathology, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka, India
|Date of Submission||08-Nov-2016|
|Date of Acceptance||21-Nov-2016|
|Date of Web Publication||19-Dec-2016|
Dr. Karthik Kasireddy
Department of Pathology, Sri Devaraj Urs Medical College, Tamaka, Kolar, Karnataka
Source of Support: None, Conflict of Interest: None
Introduction: Invasive breast cancer (BC) is the most common carcinoma in women. It accounts for 22% of all female cancers. Most tumors are derived from mammary duct epithelium, and up to 75% of BCs are ductal carcinomas. The second most common tumor is invasive lobular carcinoma. However, there are many variants which are less common but well defined by the World Health Organization classification. They comprise <10% of breast tumors. Their clinical behavior differs greatly. Hence, it is important to know their main histomorphological features to make the best treatment of choice and to foresee prognosis.
Aims and Objectives: To study the histomorphological features, incidence, and clinical features of rare invasive epithelial tumors of the breast.
Materials and Methods: This study was done in the department of pathology, Sri Devaraj Urs Medical College, Kolar. All the neoplastic breast lesions over a period of 5 years (July 2010-September 2015) are included in the study. Clinical features and other details (estrogen receptor/progesterone receptor, human epidermal receptor-2, lymph nodes) are obtained from the department (surgery) records. Specimens are received and preserved in 10% formalin and are subjected to routine histopathological processing. Hematoxylin and eosin sections are studied, and a morphological diagnosis is given. All rare invasive epithelial breast tumors will be reviewed meticulously.
Results and Conclusion: A total number of invasive epithelial tumors of breast were 105. The most common presenting symptom was breast lump. Rare invasive epithelial breast tumors account to 28.5%. The age range from 15 to 70 years. Most common, rare invasive epithelial tumor in our study is medullary carcinoma. Hence, it is imperative to always maintain a Hawks vigil during microscopic diagnosis to know prognosis of the condition and to facilitate early and prompt treatment to the patient.
Keywords: Breast, epithelial, invasive
|How to cite this article:|
Kasireddy K, Manjula K, Prasad C. Clinicopathological study of rare invasive epithelial tumors of breast: An institutional study. BLDE Univ J Health Sci 2016;1:125-7
|How to cite this URL:|
Kasireddy K, Manjula K, Prasad C. Clinicopathological study of rare invasive epithelial tumors of breast: An institutional study. BLDE Univ J Health Sci [serial online] 2016 [cited 2020 Jul 4];1:125-7. Available from: http://www.bldeujournalhs.in/text.asp?2016/1/2/125/196102
Breast cancer (BC) is a heterogeneous disease that encompasses several distinct entities with remarkably different characteristics. Although breast lesions are more common than other organ lesions, they deserve a special place in every pathologist mind due to the diversity of lesions which can range from simple fibroadenoma to various carcinomas including most common infiltrating ductal carcinomas to rarer entities such as medullary carcinoma, angiosarcoma, lobular carcinoma, papillary carcinoma, metaplastic carcinoma, and neuroendocrine carcinoma, which can be compared to an oasis in desert.
One of the very important cancer characteristics is its histological type. Histological type is associated with different epidemiology, diagnostic issues, clinical course, and prognosis. The World Health Organization (WHO) presents a detailed classification of BCs. According to this classification, cancers are divided into epithelial (such as invasive ductal carcinoma, invasive lobular carcinoma, tubular carcinoma, medullary carcinoma, mucinous carcinoma, and others), mesenchymal tumors (such as hemangioma, myofibroblastoma, lipoma, neurofibroma, leiomyoma, and others), fibroepithelial tumors (fibroadenoma, phylloides tumor, mammary hamartoma). Malignant lymphoma (diffuse large b-cell lymphoma, Burkitt lymphoma, follicular lymphoma), metastatic tumors can also be found in the breast. The WHO also marks tumors of the nipple, male BC, and myoepithelial lesions.
Invasive BC is the most common carcinoma in women. It accounts for 22% of all female cancers. Most tumors are derived from mammary duct epithelium, and up to 75% of BCs are Invasive ductal carcinomas - not otherwise specified. The second most common tumor is invasive lobular carcinoma. However, there are many variants which are less common but well defined by WHO classification. They comprise <10% of breast tumors.
Their clinical behavior differs greatly. Hence, it is important to know their main histomorphological features to make the best treatment of choice and to foresee prognosis.
Aims and objectives
To study the histomorphological features incidence and clinical features of rare invasive epithelial tumors of the breast at our Institution.
| Materials and Methods|| |
This retrospective study was done in the Department of Pathology, Sri Devaraj Urs Medical College, Kolar. All the neoplastic breast lesions over a period of 5 years (July 2010-September 2015) were included in the study.
Clinical features and other details (estrogen receptor/progesterone receptor, human epidermal receptor-2, lymph nodes) were obtained from the department records.
Histopathological examination was done on 10% formalin fixed and paraffin processed tissues from surgically resected specimens and stained by hematoxylin and eosin. Hematoxylin and eosin sections were studied, and a morphological diagnosis was given. All rare invasive epithelial breast tumors were reviewed meticulously by two different pathologists and reported.
| Results|| |
A total of 387 cases were studied over a period of 5 years. Of the 387 cases, benign lesions constituted 72.8% of cases whereas malignant lesions were 27.1% as shown in [Table 1]. The age ranged between 15 and 70 years. The most common presenting symptom was lump in both benign and malignant groups. [Table 1] shows different histopathological lesions in benign and malignant groups. In the benign group, fibroadenoma was the most common lesion encountered in 64.5% of cases. In the malignant group, infiltrating duct carcinoma was the most common lesion seen in 71.4%. Among the rare invasive epithelial tumors of breast, medullary carcinoma was most common and encountered in 13.3% followed by metaplastic carcinoma (4.7%), lobular carcinoma (2.8%) [Figure 1].
|Figure 1: (a) Lobular carcinoma, (b) pleomorphic liposarcoma, (c) medullary carcinoma, (d) metaplastic carcinoma|
Click here to view
| Discussion|| |
For correct diagnosis of breast diseases, background knowledge of general features of individual breast diseases such as incidence, age distribution, symptoms, and palpatory findings are very important. Benign conditions of breast are significantly more common than the malignant conditions in the developing countries. The limited literature available suggests that benign breast disease is a common problem in the developing countries as well. 387 cases were studied over a period of 5 years. The spectrum of breast lesions in female patients in our study showed 72.8% benign lesions of various etiology and 27.1% of malignant lesions.
Malik in his study of 1724 cases over a period of 20 years reported benign lesions in 72.97% and malignant lesions in 27.3% of cases. Similar results were obtained by Iyer in 2000 and Mayun et al. in 2008. In the present study, 55.07% of the benign lesions were noted in the patients below the age of 25 years. In the same age group, Malik noted benign lesions in 51.19% of the cases and Bauer et al. in 95% of the cases. The incidence is higher in the study of Bauer et al. as the age group selected for the study was between 12 and 22 years. In the malignant group, only one case was found below 25 years of age in our study. Similar results were noted by other authors., This shows that malignant lesions are very rare in adolescent females. Lump in the breast was the most common presenting symptom in both benign and malignant groups followed by pain in 10.14% in the benign group and 12.12% in the malignant group. Dixon and Mansel conducted a study and found breast lump in 69%, breast pain in 50%, and nipple discharge in 5% of cases. Griffith studied the frequency of presenting symptoms in benign breast diseases. He found common symptoms as lump in 33% of cases followed by pain and nipple discharge and noted that the patients may present with one or more of the symptoms. In the present study, fibroadenoma was the most common benign lesion constituting 64.5% followed by fibrocystic disease in 19.8% of the patients. The study by Malik reported 55% of fibroadenoma. It has been seen that in women between adolescence and the mid-20s, the lobules and the stromal may respond to hormonal stimuli in an exaggerated fashion with the development of single and multiple fibroadenomas.
In a study done by Kumar et al. among malignant breast lesions infiltrating ductal carcinoma was encountered maximum number of cases 65.5% which is similar to our study 71.4%.
While in his study, the second predominant lesion was lobular carcinoma followed by medullary and mucinous types, while in our study, the second most common malignancy is Medullary carcinoma followed by Metaplastic and Lobular carcinoma.
| Conclusion|| |
Diagnosing rare tumors of any organ system is a challenge to every pathologist because it involves a high index of suspicion and an "Eagles Eye" to identify it, even more so when this is based on histopathology alone. Rare tumors present a treat to pathologists and clinicians because things that we do not come across very often in our life become more special when encountered suddenly. In this study, the highest incidence of rare tumor we come across is medullary carcinoma (13.3%) followed by metaplastic and lobular carcinoma. Hence, it is imperative to always maintain a Hawks vigil during microscopic diagnosis to know the prognosis of the condition and to facilitate early and prompt treatment to patient, lest we come so close to the tree that we lose sight of the forest.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kumar B, Kumar C. Study of incidence and pattern of rare tumors of breast: Study in a tertiary care centre. Basic Appl Pathol 2012;5:42-51.
Guray M, Sahin AA. Benign breast diseases: Classification, diagnosis, and management. Oncologist 2006;11:435-49.
Mahboub E. Epidemiology of cancer Saudi Arabia, 1975-1985. Ann Saudi Med 1987;7:265-6.
Desai M. Role of obstetrician and gynecologist in the management of breast lump. J Obstet Gynecol India 2003;53:389-91.
Kumar M, Ray K, Harode S, Wagh DD. The pattern of benign breast diseases in rural hospital in India. East Cent Afr J Surg 2010;15:59-64.
Abhijit MG, Anantharaman D, Bhoopal S, Ramanujam R. Benign breast diseases. Int J Res Med Sci 2013;1:73-8.
Bancroft JD, Gamble M. Theory and Practice of Histopathological Techniques. 5 th
ed. Elsevier; 2002. p. 125-200.
Shukla HS. An outline of benign breast diseases. In: Recent Advances of Surgery. Jaypee Brothers Medical Publishers; 1992.
Malik R, Bharadwaj VK. Breast lesions in young females - A 20-year study for significance of early recognition. Indian J Pathol Microbiol 2003;46:559-62.
Iyer SP. Epidemiology of benign breast diseases in females of child bearing age group. Bombay Hosp J 2000;42:141-6.
Mayun AA, Pindiga UH, Babayo UD. Pattern of histopathological diagnosis of breast lesions in Gombe, Nigeria. Niger J Med 2008;17:159-62.
Bauer BS, Jones KM, Talbot CW. Mammary masses in the adolescent female. Surg Gynecol Obstet 1987;165:63-5.
Dixon JM, Mansel RE. ABC of breast diseases. Symptoms assessment and guidelines for referral. BMJ 1994;309:722-6.
Griffith CD. Benign breast disease. In: Sengupta BS, Chattopadhyay SK, Varma TR, editors. Gynaecology for Post Graduates and Practitioners. New Delhi: BI Publications; 1998. p. 464-75.
Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.